# KETOROLAC TROMETHAMINE
> **ANDA217166** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2023-06-20
## Drug
- **FDA Application Number:** ANDA217166
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** KETOROLAC TROMETHAMINE
- **Generic name:** KETOROLAC TROMETHAMINE
- **Active ingredients:** KETOROLAC TROMETHAMINE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2023-06-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217166)
---
*AI Analytics · CC0 1.0*